Ed -- at Pharmalot 3.0 -- Catches Up To Our Fosamax® Femur Fracture MDL Post -- Of Last Week

My buddy Ed is on this -- using the New jersey Law Journal feed for his squib -- in the Wall Street Journal.

As our readers know, we had this last weekend, on Saturday morning. It happened last Friday.

. . . .A federal judge in Trenton, N.J., dismissed the last remaining 570 cases [Editors' NOTE: Femur Fracture Cases ONLY] in multidistrict litigation over Merck’s osteoporosis drug Fosamax, but the cases could be reinstated if plaintiffs win an appeal pending before a federal appeals court, The New Jersey Law Journal writes. . . .

So it goes. Onward. Ever, and ever. . . onward.